AI Drug Designer Isomorphic Details Lofty Plans for $2.1B in New Funding (opens in new tab)

Covers The Isomorphic Labs Drug Design Engine unlocks a new frontier beyond AlphaFold

Isomorphic previously raised $600 million in external funding last year, which was also led by NYC’s Thrive Capital. The post AI Drug Designer Isomorphic Details Lofty Plans for $2.1B in New Funding appeared first on The Daily Upside.

Read the original article